Insider Stock Trading History of Boston Avenue Capital


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Boston Avenue Capital since year 2005. The trader's CIK number is 1297972. At the time of this reporting, Boston Avenue Capital is the 10% Owner of Eden Bioscience Corp . (stock ticker symbol eden). See this page for all insider trading activities at Eden Bioscience Corp .

Note that in the past Boston Avenue Capital also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Boston Avenue Capital since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-05-29 EDEN Eden Bioscience Corp Buy 11,740 1.07 12,561
2007-02-21 MALL Pc Mall Inc Sale 63,926 13.72 877,064
2007-02-20 MALL Pc Mall Inc Sale 90,447 13.68 1,237,767
2006-11-24 SLGD Scotts Liquid Gold Inc Buy 18,400 .81 14,904
2006-11-13 SLDG Scotts Liquid Gold Inc Buy 2,500 .83 2,075
2006-06-28 AMPH American Physicians Service Group Inc Sale 35,000 14.75 516,250
2006-05-12 CHRZ Computer Horizons Corp Buy 138,048 5.00 690,240
2006-02-24 COLL Collins Industries Inc Buy 18,000 7.25 130,500
2006-02-27 COLL Collins Industries Inc Buy 16,000 7.00 112,000
2006-02-21 COLL Collins Industries Inc Buy 16,770 6.50 109,005
2006-02-09 COLL Collins Industries Inc Buy 32,500 6.70 217,750
2006-02-03 COLL Collins Industries Inc Buy 1,600 6.41 10,256
2006-01-30 COLL Collins Industries Inc Buy 3,500 6.30 22,050
2006-01-26 TSC Stephan Co Buy 3,400 3.48 11,832
2005-12-22 MALL Pc Mall Inc Buy 6,609 5.52 36,481
2005-12-21 MALL Pc Mall Inc Buy 49,139 5.56 273,065
2005-12-12 MALL Pc Mall Inc Buy 4,100 5.53 22,673

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boston Avenue Capital (10% Owner of Eden Bioscience Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.